Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome



Status:Completed
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:50 - Any
Updated:1/27/2018
Start Date:July 2016
End Date:January 5, 2018

Use our guide to learn which trials are right for you!

Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial: Further Study, Health Outcome

This study is a retrospective review of the data collected in a previously completed
randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized,
Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial"
(NCT00120874). As part of the previously completed RCT, participants with Alzheimer's Disease
(AD) were randomly placed into one of two groups: memantine, or memantine plus an
individualized management program consisting of home visits, educational sessions for
caregivers, and a caregiver support group. Participants received the study intervention for
28 weeks; study follow-up lasted for 52 weeks.

The collected data from the existing study books from the 28 week treatment portion of the
RCT will be carefully examined with respect to each of the research questions for the present
retrospective study.


Inclusion Criteria:

- Previously participated in the "Memantine and Comprehensive, Individualized, Patient
Centered Management of Alzheimer's Disease: A Randomized Controlled Trial" study.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials